← Back to Search

Virtual Reality for Cancer Patients (OU-SCC VR Trial)

N/A
Waitlist Available
Led By Christina Henson, MD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

OU-SCC VR Trial Summary

This trial will test if virtual reality can help cancer patients better cope with their treatment by reducing stress and increasing adherence to the therapy.

Eligible Conditions
  • Breast Cancer
  • Head and Neck Cancers

OU-SCC VR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of overall adherence to radiation therapy
Proportion of patients reporting ease of use for VR sessions
Proportion of patients who complete 2 VR sessions
Secondary outcome measures
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v2.0 - Social Isolation - Short Form 8a (SI)
Change in brief symptom inventory
Change in state trait anxiety scale

OU-SCC VR Trial Design

1Treatment groups
Experimental Treatment
Group I: Virtual Reality SessionsExperimental Treatment1 Intervention
Patients will undergo at least two VR sessions. One prior to and one during the course of radiation treatment.

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,610 Total Patients Enrolled
2 Trials studying Breast Cancer
330 Patients Enrolled for Breast Cancer
Christina Henson, MDPrincipal InvestigatorStephenson Cancer Center
2 Previous Clinical Trials
3,523 Total Patients Enrolled

Media Library

Virtual Reality Sessions Clinical Trial Eligibility Overview. Trial Name: NCT05263648 — N/A
Breast Cancer Research Study Groups: Virtual Reality Sessions
Breast Cancer Clinical Trial 2023: Virtual Reality Sessions Highlights & Side Effects. Trial Name: NCT05263648 — N/A
Virtual Reality Sessions 2023 Treatment Timeline for Medical Study. Trial Name: NCT05263648 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants being taken for this investigation at present?

"Clinicaltrials.gov states that the enrollment period for this medical trial has concluded, as it was last modified on June 9th 2022. Despite no longer being active in recruitment, there are currently 1849 other trials actively seeking participants."

Answered by AI
~0 spots leftby Sep 2024